References
Singer ME. Cost-effectiveness analysis: developing nations left behind. Pharmacoeconomics 2008; 26 (5): 359–61
Augustovski F, Iglesias C, Manca A, et al. Generalisability of health economic evaluations in Latin America and the Caribbean region. Pharmacoeconomics 2009; 27 (11): 919–29
Tantivess S, Teerawattananon Y, Mills A. Strengthening cost-effectiveness analysis in Thailand through the establishment of the Health Intervention and Technology Assessment Program. Pharmacoeconomics 2009; 27 (11): 931–45
Yang B-M. The future of health technology assessment in healthcare decision making in Asia. Pharmacoeconomics 2009; 27 (11): 891–901
Shillcutt SD, Walker DG, Goodman CA, et al. Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules. Pharmacoeconomics 2009; 27 (11): 903–17
Babigumira JB, Sethi AK, Smyth KA, et al. Cost effectiveness of facility-based care, home-based care and mobile clinics for provision of antiretroviral therapy in Uganda. Pharmacoeconomics 2009; 27 (11): 963–73
Shih Y-CT, Pan I-W, Tsai Y-W. Information technology facilitates cost-effectiveness analysis in developing countries. Pharmacoeconomics 2009; 27 (11): 947–61
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singer, M.E. Developing Nations Special Issue. Pharmacoeconomics 27, 887–889 (2009). https://doi.org/10.2165/11531470-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11531470-000000000-00000